New nitromethyl ketones, process for preparing them and compositions containing them
申请人:Merck Patent GmbH
公开号:US20030171422A1
公开(公告)日:2003-09-11
The present invention relates to the compounds of formula:
1
in which R
1
, R
2
, R
3
, E, A, X, Z, p and n are as defined herein. These compounds are aldose reductase inhibitors.
NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM
申请人:——
公开号:US20030069312A1
公开(公告)日:2003-04-10
The present invention relates to the compounds of formula:
1
in which R
1
, R
2
, R
3
, E, A, X, Z, p and n are as defined herein. These compounds are aldose reductase inhibitors.
NEW NITROMETHYL KETONES, PROCESS FOR PREPARING THEM AND COMPOSITIONS CONTAINING THEM
申请人:MERCK PATENT GmbH
公开号:EP0983226A1
公开(公告)日:2000-03-08
METHOD FOR PREDICTING A SUBJECTS RESPONSE TO SLC MODULATOR THERAPY
申请人:THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
公开号:US20210254158A1
公开(公告)日:2021-08-19
The present invention provides, inter alia, methods for treating or ameliorating the effects of a disorder, such as schizophrenia or bipolar disorder, by increasing or decreasing proline levels. Further provided are methods of predicting and monitoring the clinical response in a patient, and diagnostic systems for identifying a patient likely to benefit from proline modulation.